These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 26665011)

  • 1. RNA-Based Vaccines in Cancer Immunotherapy.
    McNamara MA; Nair SK; Holl EK
    J Immunol Res; 2015; 2015():794528. PubMed ID: 26665011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy.
    Copur M
    Oncology (Williston Park); 2021 Apr; 35(4):190-198. PubMed ID: 33893760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA Cancer Vaccines.
    Fiedler K; Lazzaro S; Lutz J; Rauch S; Heidenreich R
    Recent Results Cancer Res; 2016; 209():61-85. PubMed ID: 28101688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells in cancer immunotherapy.
    Schuler G
    Eur J Immunol; 2010 Aug; 40(8):2123-30. PubMed ID: 20853498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA-based dendritic cell vaccines.
    Benteyn D; Heirman C; Bonehill A; Thielemans K; Breckpot K
    Expert Rev Vaccines; 2015 Feb; 14(2):161-76. PubMed ID: 25196947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically engineered dendritic cell-based cancer vaccines (review).
    Bubeník J
    Int J Oncol; 2001 Mar; 18(3):475-8. PubMed ID: 11179474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcutaneous delivery of DNA/mRNA for cancer therapeutic vaccination.
    Sun X; Zeng L; Huang Y
    J Gene Med; 2019 Jul; 21(7):e3089. PubMed ID: 30958606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ReNAissanCe of mRNA-based cancer therapy.
    Van Lint S; Renmans D; Broos K; Dewitte H; Lentacker I; Heirman C; Breckpot K; Thielemans K
    Expert Rev Vaccines; 2015 Feb; 14(2):235-51. PubMed ID: 25263094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA transfected dendritic cells as cancer vaccines.
    Mitchell DA; Nair SK
    Curr Opin Mol Ther; 2000 Apr; 2(2):176-81. PubMed ID: 11249639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect.
    Fotin-Mleczek M; Zanzinger K; Heidenreich R; Lorenz C; Thess A; Duchardt KM; Kallen KJ
    J Gene Med; 2012 Jun; 14(6):428-39. PubMed ID: 22262664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
    Shurin MR; Gregory M; Morris JC; Malyguine AM
    Expert Opin Biol Ther; 2010 Nov; 10(11):1539-53. PubMed ID: 20955111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of an antitumor response using dendritic cells transfected with DNA constructs encoding the HLA-A*02:01-restricted epitopes of tumor-associated antigens in culture of mononuclear cells of breast cancer patients.
    Sennikov SV; Shevchenko JA; Kurilin VV; Khantakova JN; Lopatnikova JA; Gavrilova EV; Maksyutov RA; Bakulina AY; Sidorov SV; Khristin AA; Maksyutov AZ
    Immunol Res; 2016 Feb; 64(1):171-80. PubMed ID: 26590947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell preparation for immunotherapeutic interventions.
    Simon T; Fonteneau JF; Grégoire M
    Immunotherapy; 2009 Mar; 1(2):289-302. PubMed ID: 20635946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA therapeutics in cancer immunotherapy.
    Beck JD; Reidenbach D; Salomon N; Sahin U; Türeci Ö; Vormehr M; Kranz LM
    Mol Cancer; 2021 Apr; 20(1):69. PubMed ID: 33858437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunological effects of mRNA vaccines in malignant diseases.
    Heine A; Juranek S; Brossart P
    Mol Cancer; 2021 Mar; 20(1):52. PubMed ID: 33722265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-loaded dendritic cells: more than a
    Joshi A; Tandel N; Tyagi P; Dalai SK; Bisen PS; Tyagi RK
    Immunotherapy; 2019 Sep; 11(13):1129-1147. PubMed ID: 31390917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.
    Holtkamp S; Kreiter S; Selmi A; Simon P; Koslowski M; Huber C; Türeci O; Sahin U
    Blood; 2006 Dec; 108(13):4009-17. PubMed ID: 16940422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccination.
    Michiels A; Tuyaerts S; Bonehill A; Heirman C; Corthals J; Thielemans K
    Methods Mol Biol; 2008; 423():155-63. PubMed ID: 18370196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D; Appel S
    Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.
    Bhargava A; Mishra D; Banerjee S; Mishra PK
    Immunotherapy; 2012 Jul; 4(7):703-18. PubMed ID: 22853757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.